{"id":1180,"date":"2021-04-08T10:03:21","date_gmt":"2021-04-08T10:03:21","guid":{"rendered":"https:\/\/atonco-pharma.com\/312-2\/"},"modified":"2023-03-20T18:13:00","modified_gmt":"2023-03-20T18:13:00","slug":"atonco","status":"publish","type":"page","link":"https:\/\/atonco-pharma.com\/en\/","title":{"rendered":"Home2"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Header&#8221; _builder_version=&#8221;4.16&#8243; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_type=&#8221;circular&#8221; background_color_gradient_direction_radial=&#8221;top&#8221; background_color_gradient_stops=&#8221;rgba(255,255,255,0.64) 0%|#ffffff 60%&#8221; background_color_gradient_start=&#8221;rgba(255,255,255,0.64)&#8221; background_color_gradient_end=&#8221;#ffffff&#8221; background_color_gradient_end_position=&#8221;60%&#8221; background_enable_image=&#8221;off&#8221; parallax=&#8221;on&#8221; custom_padding=&#8221;20px|0px|0|0px|false|false&#8221; custom_width_px__hover=&#8221;1080px&#8221; custom_width_px__hover_enabled=&#8221;1080px&#8221; custom_width_percent__hover=&#8221;80%&#8221; custom_width_percent__hover_enabled=&#8221;80%&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; parallax_1__hover=&#8221;off&#8221; parallax_1__hover_enabled=&#8221;off&#8221; parallax_2__hover=&#8221;off&#8221; parallax_2__hover_enabled=&#8221;off&#8221; parallax_3__hover=&#8221;off&#8221; parallax_3__hover_enabled=&#8221;off&#8221; parallax_method_1__hover=&#8221;on&#8221; parallax_method_1__hover_enabled=&#8221;on&#8221; parallax_method_2__hover=&#8221;on&#8221; parallax_method_2__hover_enabled=&#8221;on&#8221; parallax_method_3__hover=&#8221;on&#8221; parallax_method_3__hover_enabled=&#8221;on&#8221; use_background_color_gradient__hover=&#8221;off&#8221; use_background_color_gradient__hover_enabled=&#8221;off&#8221; background_color_gradient_start__hover=&#8221;#2b87da&#8221; background_color_gradient_start__hover_enabled=&#8221;#2b87da&#8221; background_color_gradient_end__hover=&#8221;#29c4a9&#8243; background_color_gradient_end__hover_enabled=&#8221;#29c4a9&#8243; background_color_gradient_type__hover=&#8221;linear&#8221; background_color_gradient_type__hover_enabled=&#8221;linear&#8221; background_color_gradient_direction__hover=&#8221;180deg&#8221; background_color_gradient_direction__hover_enabled=&#8221;180deg&#8221; background_color_gradient_direction_radial__hover=&#8221;center&#8221; background_color_gradient_direction_radial__hover_enabled=&#8221;center&#8221; background_color_gradient_start_position__hover=&#8221;0%&#8221; background_color_gradient_start_position__hover_enabled=&#8221;0%&#8221; background_color_gradient_end_position__hover=&#8221;100%&#8221; background_color_gradient_end_position__hover_enabled=&#8221;100%&#8221; background_color_gradient_overlays_image__hover=&#8221;off&#8221; background_color_gradient_overlays_image__hover_enabled=&#8221;off&#8221; parallax__hover=&#8221;off&#8221; parallax__hover_enabled=&#8221;off&#8221; parallax_method__hover=&#8221;on&#8221; parallax_method__hover_enabled=&#8221;on&#8221; background_size__hover=&#8221;cover&#8221; background_size__hover_enabled=&#8221;cover&#8221; background_position__hover=&#8221;center&#8221; background_position__hover_enabled=&#8221;center&#8221; background_repeat__hover=&#8221;no-repeat&#8221; background_repeat__hover_enabled=&#8221;no-repeat&#8221; background_blend__hover=&#8221;normal&#8221; background_blend__hover_enabled=&#8221;normal&#8221; allow_player_pause__hover=&#8221;off&#8221; allow_player_pause__hover_enabled=&#8221;off&#8221; background_video_pause_outside_viewport__hover=&#8221;on&#8221; background_video_pause_outside_viewport__hover_enabled=&#8221;on&#8221; inner_shadow__hover=&#8221;off&#8221; inner_shadow__hover_enabled=&#8221;off&#8221; make_fullwidth__hover=&#8221;off&#8221; make_fullwidth__hover_enabled=&#8221;off&#8221; use_custom_width__hover=&#8221;off&#8221; use_custom_width__hover_enabled=&#8221;off&#8221; width_unit__hover=&#8221;on&#8221; width_unit__hover_enabled=&#8221;on&#8221; make_equal__hover=&#8221;off&#8221; make_equal__hover_enabled=&#8221;off&#8221; use_custom_gutter__hover=&#8221;off&#8221; use_custom_gutter__hover_enabled=&#8221;off&#8221; gutter_width__hover=&#8221;3&#8243; gutter_width__hover_enabled=&#8221;3&#8243; border_radii__hover=&#8221;on||||&#8221; border_radii__hover_enabled=&#8221;on||||&#8221; box_shadow_style__hover=&#8221;none&#8221; box_shadow_style__hover_enabled=&#8221;none&#8221; box_shadow_color__hover=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_color__hover_enabled=&#8221;rgba(0,0,0,0.3)&#8221; max_width__hover=&#8221;100%&#8221; max_width__hover_enabled=&#8221;100%&#8221; filter_hue_rotate__hover=&#8221;0deg&#8221; filter_hue_rotate__hover_enabled=&#8221;0deg&#8221; filter_saturate__hover=&#8221;100%&#8221; filter_saturate__hover_enabled=&#8221;100%&#8221; filter_brightness__hover=&#8221;100%&#8221; filter_brightness__hover_enabled=&#8221;100%&#8221; filter_contrast__hover=&#8221;100%&#8221; filter_contrast__hover_enabled=&#8221;100%&#8221; filter_invert__hover=&#8221;0%&#8221; filter_invert__hover_enabled=&#8221;0%&#8221; filter_sepia__hover=&#8221;0%&#8221; filter_sepia__hover_enabled=&#8221;0%&#8221; filter_opacity__hover=&#8221;100%&#8221; filter_opacity__hover_enabled=&#8221;100%&#8221; filter_blur__hover=&#8221;0px&#8221; filter_blur__hover_enabled=&#8221;0px&#8221; mix_blend_mode__hover=&#8221;normal&#8221; mix_blend_mode__hover_enabled=&#8221;normal&#8221; animation_style__hover=&#8221;none&#8221; animation_style__hover_enabled=&#8221;none&#8221; animation_repeat__hover=&#8221;once&#8221; animation_repeat__hover_enabled=&#8221;once&#8221; animation_direction__hover=&#8221;center&#8221; animation_direction__hover_enabled=&#8221;center&#8221; animation_duration__hover=&#8221;1000ms&#8221; animation_duration__hover_enabled=&#8221;1000ms&#8221; animation_delay__hover=&#8221;0ms&#8221; animation_delay__hover_enabled=&#8221;0ms&#8221; animation_intensity_slide__hover=&#8221;50%&#8221; animation_intensity_slide__hover_enabled=&#8221;50%&#8221; animation_intensity_zoom__hover=&#8221;50%&#8221; animation_intensity_zoom__hover_enabled=&#8221;50%&#8221; animation_intensity_flip__hover=&#8221;50%&#8221; animation_intensity_flip__hover_enabled=&#8221;50%&#8221; animation_intensity_fold__hover=&#8221;50%&#8221; animation_intensity_fold__hover_enabled=&#8221;50%&#8221; animation_intensity_roll__hover=&#8221;50%&#8221; animation_intensity_roll__hover_enabled=&#8221;50%&#8221; animation_starting_opacity__hover=&#8221;0%&#8221; animation_starting_opacity__hover_enabled=&#8221;0%&#8221; animation_speed_curve__hover=&#8221;ease-in-out&#8221; animation_speed_curve__hover_enabled=&#8221;ease-in-out&#8221; hover_transition_duration__hover=&#8221;300ms&#8221; hover_transition_duration__hover_enabled=&#8221;300ms&#8221; hover_transition_delay__hover=&#8221;0ms&#8221; hover_transition_delay__hover_enabled=&#8221;0ms&#8221; hover_transition_speed_curve__hover=&#8221;ease&#8221; hover_transition_speed_curve__hover_enabled=&#8221;ease&#8221; background_color_gradient_stops__hover=&#8221;#2b87da 0%|#29c4a9 100%&#8221;][et_pb_row _builder_version=&#8221;4.17.4&#8243; background_color=&#8221;RGBA(0,0,0,0)&#8221; custom_padding=&#8221;14px|||||&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; parallax__hover=&#8221;off&#8221; parallax_method__hover=&#8221;on&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_divider color=&#8221;#1ca5ff&#8221; divider_weight=&#8221;16px&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;#0C71C3&#8243; max_width=&#8221;48px&#8221; module_alignment=&#8221;center&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][et_pb_text _builder_version=&#8221;4.17.4&#8243; text_font=&#8221;Donegal One||||||||&#8221; text_text_color=&#8221;#0C71C3&#8243; text_line_height=&#8221;2.9em&#8221; header_font=&#8221;B612|600|||||||&#8221; header_font_size=&#8221;29px&#8221; header_line_height=&#8221;1.3em&#8221; header_2_font=&#8221;Poppins|600|||||||&#8221; header_2_font_size=&#8221;32px&#8221; header_2_line_height=&#8221;1.6em&#8221; text_orientation=&#8221;center&#8221; max_width=&#8221;700px&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;-18px|||||&#8221; custom_padding=&#8221;12px|||||&#8221; header_2_font_size_tablet=&#8221;24px&#8221; header_2_font_size_phone=&#8221;18px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; text_text_shadow_style=&#8221;preset4&#8243; text_text_shadow_color=&#8221;rgba(255,255,255,0.63)&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1><em>Astatine against cancer<\/em><\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/atonco-pharma.com\/wp-content\/uploads\/2021\/06\/Untitled-design.jpg&#8221; title_text=&#8221;Untitled design&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-32px|||||&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; text_font=&#8221;||||||||&#8221; text_line_height=&#8221;2em&#8221; header_font=&#8221;Poppins|600|||||||&#8221; header_font_size=&#8221;40px&#8221; header_line_height=&#8221;1.3em&#8221; header_2_font=&#8221;Poppins|600|||||||&#8221; header_2_font_size=&#8221;32px&#8221; header_2_line_height=&#8221;1.6em&#8221; text_orientation=&#8221;center&#8221; max_width=&#8221;700px&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;||16px|||&#8221; header_2_font_size_tablet=&#8221;24px&#8221; header_2_font_size_phone=&#8221;18px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>About Atonco<\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-21px|||||&#8221; custom_padding=&#8221;8px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Atonco is a clinical-stage radiopharmaceutical company developing innovative radiopharmaceuticals using astatine-211, an alpha emitting radionuclide for the treatment of cancer. Atonco, founded in 2019 and built with an experienced and passionate team, has exclusive worldwide licenses for the use of an antibody and innovative proprietary radiolabeling technology.<\/p>\n<p>Atonco, based on a disruptive and innovative alpha-immunotherapy, meets two goals\u00a0:<\/p>\n<p>&#8211; clinical indications with real unmet therapeutic needs<\/p>\n<p>&#8211; rapidly accessible tumor targets, adapted to the short half-life of astatine-211 (7.2 hours) and with a small size suited to the very short path length of emitted alpha particles.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/atonco-pharma.com\/wp-content\/uploads\/2021\/06\/Untitled-design-3.jpg&#8221; title_text=&#8221;Untitled design (3)&#8221; show_bottom_space=&#8221;off&#8221; _builder_version=&#8221;4.16&#8243; max_width_tablet=&#8221;400px&#8221; max_width_phone=&#8221;&#8221; max_width_last_edited=&#8221;on|tablet&#8221; min_height=&#8221;261px&#8221; custom_margin=&#8221;||35px|||&#8221; custom_padding=&#8221;||2px|||&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;right&#8221; animation_intensity_slide=&#8221;1%&#8221; always_center_on_mobile=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.17.4&#8243; text_font=&#8221;||||||||&#8221; text_line_height=&#8221;2em&#8221; header_font=&#8221;Poppins|600|||||||&#8221; header_font_size=&#8221;40px&#8221; header_line_height=&#8221;1.3em&#8221; header_2_font=&#8221;Poppins|600|||||||&#8221; header_2_font_size=&#8221;32px&#8221; header_2_line_height=&#8221;1.6em&#8221; max_width=&#8221;700px&#8221; min_height=&#8221;208.5px&#8221; custom_margin=&#8221;-35px|||||&#8221; custom_padding=&#8221;2px||0px|||&#8221; header_2_font_size_tablet=&#8221;24px&#8221; header_2_font_size_phone=&#8221;18px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Mission statement<\/h2>\n<p><strong><em>\u201cOffer cancer patients a longer and a better quality of life.\u201d<\/em><\/strong><\/p>\n<p>Atonco team aims at offering to patients an innovative therapy to destroy the last remaining cancer cells from residual disease left after conventional cancer treatments including radiation therapy, chemotherapy and immunotherapy.<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.16&#8243; text_font=&#8221;||||||||&#8221; text_line_height=&#8221;2em&#8221; header_font=&#8221;Poppins|600|||||||&#8221; header_font_size=&#8221;40px&#8221; header_line_height=&#8221;1.3em&#8221; header_2_font=&#8221;Poppins|600|||||||&#8221; header_2_font_size=&#8221;32px&#8221; header_2_line_height=&#8221;1.6em&#8221; max_width=&#8221;700px&#8221; min_height=&#8221;254.5px&#8221; custom_margin=&#8221;-26px|||||&#8221; custom_padding=&#8221;0px||0px|||&#8221; header_2_font_size_tablet=&#8221;24px&#8221; header_2_font_size_phone=&#8221;18px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Vision of the future<\/h2>\n<p><strong><em>&#8220;<\/em><\/strong>We believe that alpha-immunotherapy using astatine-211 holds great promise in certain clinical indications. Our vision is to confirm the future of alpha-immunotherapy as a promising targeted radiation therapy for better quality and longer life for cancer patients.&#8221;<\/p>\n<p><strong><em>\u201d<\/em><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astatine against cancerAbout AtoncoAtonco is a clinical-stage radiopharmaceutical company developing innovative radiopharmaceuticals using astatine-211, an alpha emitting radionuclide for the treatment of cancer. Atonco, founded in 2019 and built with an experienced and passionate team, has exclusive worldwide licenses for the use of an antibody and innovative proprietary radiolabeling technology. Atonco, based on a disruptive [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-1180","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Atonco: the future of alpha-immunotherapy<\/title>\n<meta name=\"description\" content=\"ATONCO develops molecularly targeted therapeutic oncology solutions using Astatine-211 for better quality and longer life for cancer patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atonco: the future of alpha-immunotherapy\" \/>\n<meta property=\"og:description\" content=\"ATONCO develops molecularly targeted therapeutic oncology solutions using Astatine-211 for better quality and longer life for cancer patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-20T18:13:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/atonco-pharma.com\/en\/\",\"url\":\"https:\/\/atonco-pharma.com\/en\/\",\"name\":\"Atonco: the future of alpha-immunotherapy\",\"isPartOf\":{\"@id\":\"https:\/\/atonco-pharma.com\/en\/#website\"},\"datePublished\":\"2021-04-08T10:03:21+00:00\",\"dateModified\":\"2023-03-20T18:13:00+00:00\",\"description\":\"ATONCO develops molecularly targeted therapeutic oncology solutions using Astatine-211 for better quality and longer life for cancer patients.\",\"breadcrumb\":{\"@id\":\"https:\/\/atonco-pharma.com\/en\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/atonco-pharma.com\/en\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/atonco-pharma.com\/en\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/atonco-pharma.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/atonco-pharma.com\/en\/#website\",\"url\":\"https:\/\/atonco-pharma.com\/en\/\",\"name\":\"Atonco Pharma\",\"description\":\"Immunoth\u00e9rapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atonco: the future of alpha-immunotherapy","description":"ATONCO develops molecularly targeted therapeutic oncology solutions using Astatine-211 for better quality and longer life for cancer patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/","og_locale":"en_US","og_type":"article","og_title":"Atonco: the future of alpha-immunotherapy","og_description":"ATONCO develops molecularly targeted therapeutic oncology solutions using Astatine-211 for better quality and longer life for cancer patients.","og_url":"https:\/\/atonco-pharma.com\/en\/","og_site_name":"Atonco Pharma","article_modified_time":"2023-03-20T18:13:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco: the future of alpha-immunotherapy","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"datePublished":"2021-04-08T10:03:21+00:00","dateModified":"2023-03-20T18:13:00+00:00","description":"ATONCO develops molecularly targeted therapeutic oncology solutions using Astatine-211 for better quality and longer life for cancer patients.","breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Home2"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco Pharma","description":"Immunoth\u00e9rapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1180"}],"version-history":[{"count":6,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1180\/revisions"}],"predecessor-version":[{"id":2168,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1180\/revisions\/2168"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}